ES532640A0 - Procedimiento para la obtencion de un preparado que contiene factor viii (ahf) - Google Patents

Procedimiento para la obtencion de un preparado que contiene factor viii (ahf)

Info

Publication number
ES532640A0
ES532640A0 ES532640A ES532640A ES532640A0 ES 532640 A0 ES532640 A0 ES 532640A0 ES 532640 A ES532640 A ES 532640A ES 532640 A ES532640 A ES 532640A ES 532640 A0 ES532640 A0 ES 532640A0
Authority
ES
Spain
Prior art keywords
factor viii
ahf
units
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES532640A
Other languages
English (en)
Other versions
ES8505822A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of ES8505822A1 publication Critical patent/ES8505822A1/es
Publication of ES532640A0 publication Critical patent/ES532640A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES532640A 1983-05-20 1984-05-18 Procedimiento para la obtencion de un preparado que contiene factor viii (ahf) Granted ES532640A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0185883A AT379510B (de) 1983-05-20 1983-05-20 Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation

Publications (2)

Publication Number Publication Date
ES8505822A1 ES8505822A1 (es) 1985-06-16
ES532640A0 true ES532640A0 (es) 1985-06-16

Family

ID=3522525

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532640A Granted ES532640A0 (es) 1983-05-20 1984-05-18 Procedimiento para la obtencion de un preparado que contiene factor viii (ahf)

Country Status (8)

Country Link
US (1) US4522751A (es)
EP (1) EP0127603B1 (es)
JP (1) JPS59222420A (es)
AT (2) AT379510B (es)
CA (1) CA1225331A (es)
DE (1) DE3475871D1 (es)
DK (1) DK158281C (es)
ES (1) ES532640A0 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
AT391809B (de) * 1988-01-12 1990-12-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutplasmaprodukten
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
FR2659557A1 (fr) * 1990-03-15 1991-09-20 Fondation Nale Transfusion San Procede de preparation d'une solution concentree de facteur viii.
FR2665364A2 (fr) * 1990-03-15 1992-02-07 Fondation Nale Transfusion San Procede de preparation d'une solution concentree de facteur viii.
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
PT2130554E (pt) 1999-02-22 2012-11-19 Univ Connecticut Formulações de factor viii isentas de albumina
ES2229931B1 (es) * 2003-10-03 2006-01-16 Grifols, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
KR101389376B1 (ko) 2007-02-23 2014-04-29 에스케이케미칼주식회사 제 ８ 인자 및 그의 유도체의 제조 및 정제 방법
US20100168018A1 (en) * 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
JP2014138614A (ja) * 2014-04-09 2014-07-31 Sk Chemicals Co Ltd 第ｖｉｉｉ因子とその誘導体の製造及び精製方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
US4104266A (en) * 1977-04-14 1978-08-01 American National Red Cross Method for preparation of antihemophilic factor
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
AT369263B (de) * 1980-08-27 1982-12-27 Immuno Ag Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
DK158281C (da) 1990-10-01
ES8505822A1 (es) 1985-06-16
AT379510B (de) 1986-01-27
JPS59222420A (ja) 1984-12-14
EP0127603A3 (en) 1986-09-03
US4522751A (en) 1985-06-11
DE3475871D1 (en) 1989-02-09
DK241584D0 (da) 1984-05-16
JPH0553777B2 (es) 1993-08-10
EP0127603B1 (de) 1989-01-04
DK158281B (da) 1990-04-30
ATE39618T1 (de) 1989-01-15
CA1225331A (en) 1987-08-11
DK241584A (da) 1984-11-21
ATA185883A (de) 1985-06-15
EP0127603A2 (de) 1984-12-05

Similar Documents

Publication Publication Date Title
ES532640A0 (es) Procedimiento para la obtencion de un preparado que contiene factor viii (ahf)
ES8501979A1 (es) Procedimiento para preparar un concentrado de factor antihemofilico
US4278594A (en) Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
NO177188C (no) Fremgangsmåte for separering av humane eller animalske plasmaproteiner
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
DE3571201D1 (en) Process for producing a high purity antihemophilic factor concentrate
ES2028913T3 (es) Procedimiento para la fabricacion de una fraccion que contiene el factor viii (ahf).
IL76929A0 (en) Preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
AT379310B (de) Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
US4264589A (en) Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
US4178285A (en) Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
ATE44750T1 (de) Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats.
McGregor et al. Tandem separation of labelled human blood platelet membrane glycoproteins by anion-exchange and gel fast protein liquid chromatography
DE3166700D1 (en) A process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form
Sahu et al. Structure of carbohydrate chains of a high-molecular-weight pulmonary glycoprotein
Walz FURTHER STUDIES ON THE GENERATION AND NATURE OF THROMBIN.
KR920005994A (ko) 전체혈장으로 혈액응고 viii 인자-반 빌레브란트 인자 복합 농축물을 제조하는 방법
BG97669A (en) Method for the preparation of antigen from immune complexes for immune disgnaostics of enzootic bovine leucosis
DK318086A (da) Praeparat til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadant praeparat

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601